|
You are here |
blog.fellstat.com | ||
| | | | |
publichealth.jhu.edu
|
|
| | | | | A new family of COVID variants are becoming dominant in the U.S. at a crucial time for vaccine decision-making. | |
| | | | |
www.yalemedicine.org
|
|
| | | | | The FDA approved updated (2023-2024 formula) COVID-19 vaccines, which are expected to keep more people from getting seriously ill with the virus, including recent strains. | |
| | | | |
www.someweekendreading.blog
|
|
| | | | | Last week several bombs were dropped: COVID vaccine efficacy with the Delta variant, breakthrough infections, asymptomatic carriers, and changes in CDC guidelines. Was the panicky media coverage at all useful? | |
| | | | |
www.nationalnursesunited.org
|
|
| | | Currently, rates of influenza and respiratory syncytial virus (RSV) are climbing rapidly across the United States. Pediatric hospitals are full. Hospitalizations for flu are the highest for this time of year in over a decade. This is happening while the Covid-19 pandemic continues. | ||